Citizens Maintains Market Outperform on AMERISAFE, Lowers Price Target to $35
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Citizens analyst Matthew J. Carletti maintains AMERISAFE (NASDAQ:AMSF) with a Market Outperform and lowers the price target from $40 to $35.
Citizens analyst Matthew J. Carletti maintains AMERISAFE (NASDAQ:AMSF) with a Market Outperform and lowers the price target from $40 to $35.